{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:11:49Z","timestamp":1774530709858,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.schres.2009.09.041","type":"journal-article","created":{"date-parts":[[2009,11,5]],"date-time":"2009-11-05T12:43:29Z","timestamp":1257425009000},"page":"35-43","source":"Crossref","is-referenced-by-count":40,"title":["QTc interval in a sample of long-term schizophrenia inpatients"],"prefix":"10.1016","volume":"116","author":[{"given":"Ram\u00f3n","family":"Ramos-R\u00edos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Arrojo-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Paz-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Carballal-Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 L.","family":"Bouz\u00f3n-Barreiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Seoane-Prado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Codesido-Barcala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Cresp\u00ed-Armenteros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram\u00f3n","family":"Fern\u00e1ndez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier D.","family":"L\u00f3pez-Mor\u00ed\u00f1igo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Tortajada-Bonaselt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J.","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"de Leon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2009.09.041_bib1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1192\/bjp.186.3.215","article-title":"Nicotine dependence and symptoms in schizophrenia: naturalistic study of complex interactions","volume":"186","author":"Aguilar","year":"2005","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2009.09.041_bib2","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation."},{"key":"10.1016\/j.schres.2009.09.041_bib3","first-page":"85","article-title":"Analytic and electrocardiographic abnormalities in schizophrenic patients admitted to an emergency service","volume":"1","author":"Armas-Barbaz\u00e1n","year":"2008","journal-title":"Rev. Psiquiatr. Salud. Ment."},{"key":"10.1016\/j.schres.2009.09.041_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12031-008-9160-9","article-title":"Genetic polymorphism of glutathione S-transferase T1 (GSTT1) and QT-interval in schizophrenia patients","volume":"38","author":"Bahaoddini","year":"2009","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.schres.2009.09.041_bib5","series-title":"Chemotherapy in Psychiatry","author":"Baldessarini","year":"1985"},{"key":"10.1016\/j.schres.2009.09.041_bib6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/hup.540","article-title":"Prolonged QTc intervals in medicated patients with schizophrenia","volume":"18","author":"Chong","year":"2003","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.schres.2009.09.041_bib7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pcad.2008.06.003","article-title":"Epidemiology of sudden cardiac death: clinical and research implications","volume":"51","author":"Chugh","year":"2008","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.schres.2009.09.041_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4088\/JCP.v62n0310","article-title":"Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis","volume":"62","author":"Czekalla","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2009.09.041_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/JCP.0b013e318166f533","article-title":"Beyond the \u201chype\u201d on the association between metabolic syndrome and atypical antipsychotics: the confounding effects of cohort, typical antipsychotics, severe mental illness, and co-morbid substance use (editorial)","volume":"28","author":"de Leon","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2009.09.041_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.schres.2005.02.010","article-title":"A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors","volume":"76","author":"de Leon","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2009.09.041_bib11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1176\/ajp.152.3.453","article-title":"Schizophrenia and smoking: an epidemiological survey in a state hospital","volume":"152","author":"de Leon","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2009.09.041_bib12","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.4088\/JCP.v66n1112","article-title":"Variables associated with alcohol, drug and daily smoking cessation in patients with severe mental illnesses","volume":"66","author":"de Leon","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2009.09.041_bib13","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.ridd.2008.10.010","article-title":"Practical guidelines for the use of new generation antipsychotics (except clozapine) in adult individuals with developmental disabilities","volume":"30","author":"de Leon","year":"2009","journal-title":"Res. Dev. Disabil."},{"key":"10.1016\/j.schres.2009.09.041_bib14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1157\/13118106","article-title":"Factors related to the length of the corrected QT interval in patients treated with antipsychotics","volume":"130","author":"Fraguas Herr\u00e1ez","year":"2008","journal-title":"Med. Clin."},{"key":"10.1016\/j.schres.2009.09.041_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/cbm.630","article-title":"QTc-interval abnormalities in a forensic population","volume":"17","author":"Girgis","year":"2007","journal-title":"Crim. Behav. Ment. Health"},{"key":"10.1016\/j.schres.2009.09.041_bib16","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1176\/appi.ajp.158.11.1774","article-title":"Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death","volume":"158","author":"Glassman","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2009.09.041_bib17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/01.jcp.0000104913.75206.62","article-title":"A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition","volume":"24","author":"Harrigan","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2009.09.041_bib18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0165-1781(00)00152-9","article-title":"Prolonged QT interval in acute psychotic patients","volume":"94","author":"Hatta","year":"2000","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2009.09.041_bib19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1176\/appi.psy.47.3.264","article-title":"Torsades de pointes associated with ziprasidone","volume":"47","author":"Heinrich","year":"2006","journal-title":"Psychosomatics"},{"issue":"suppl 6","key":"10.1016\/j.schres.2009.09.041_bib20","first-page":"11","article-title":"Schizophrenia and comorbid metabolic disorders","volume":"66","author":"Henderson","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2009.09.041_bib21","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(08)60486-9","article-title":"Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial","volume":"371","author":"Kahn","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2009.09.041_bib22","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1540-8167.2006.00573.x","article-title":"Does it all go up in smoke? Cigarette smoking and tachyarrhythmias","volume":"17","author":"Katz","year":"2006","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.schres.2009.09.041_bib23","unstructured":"Knoll AG, 1999. Zoleptil (Zotepine) Product Monograph Knoll AG. Knoll AG, Ludwigshafen, Germany."},{"key":"10.1016\/j.schres.2009.09.041_bib24","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/08039480801959323","article-title":"Schizophrenia and sudden cardiac death: a review","volume":"62","author":"Koponen","year":"2008","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.schres.2009.09.041_bib25","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/sj.jhh.1001874","article-title":"Relationship between QT interval and cardiovascular risk factors in healthy young subjects","volume":"19","author":"Leotta","year":"2005","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.schres.2009.09.041_bib26","unstructured":"Lieberman, J.A., Merrill, D., Parameswaran, S., 2009. APA guidance on the use of antipsychotic drugs and cardiac sudden death prepared by for the APA Council on Research. http:\/\/www.omh.state.ny.us\/omhweb\/advisories\/adult_antipsychotic_use_attachement.html."},{"key":"10.1016\/j.schres.2009.09.041_bib27","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.4088\/JCP.v66n1107","article-title":"QTc interval measurement and metabolic parameters in psychiatric patients taking typical or atypical antipsychotic drugs: a preliminary study","volume":"66","author":"Mackin","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2009.09.041_bib28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00125-004-1641-y","article-title":"Prevalence of obesity, glucose homeostasis disorders and metabolic syndrome in psychiatric patients taking typical or atypical antipsychotic drugs: a cross-sectional study","volume":"48","author":"Mackin","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.schres.2009.09.041_bib29","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/ageing\/32.3.326","article-title":"Impact of age on QT interval and QT dispersion in healthy subjects: a regression analysis","volume":"32","author":"Mangoni","year":"2003","journal-title":"Age Ageing"},{"key":"10.1016\/j.schres.2009.09.041_bib30","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF03160936","article-title":"QT prolongation and torsades de pointes following overdose of ziprasidone and amantadine","volume":"3","author":"Manini","year":"2007","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.schres.2009.09.041_bib31","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.schres.2009.09.041_bib32","series-title":"Manual de Toxicolog\u00eda B\u00e1sica","author":"Menc\u00edas","year":"2000"},{"key":"10.1016\/j.schres.2009.09.041_bib33","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1586\/14737175.7.7.829","article-title":"Cardiovascular effects of antipsychotics","volume":"7","author":"Michelsen","year":"2007","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.schres.2009.09.041_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.schres.2006.06.026","article-title":"Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline","volume":"86","author":"Nasrallah","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2009.09.041_bib35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijcard.2006.04.087","article-title":"Monitoring of QT interval in patients treated with psychotropic drugs","volume":"117","author":"Novotny","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.schres.2009.09.041_bib36","first-page":"149","article-title":"Risk factors of QT interval prolongation in Japanese patients with schizophrenia","volume":"11","author":"Ozeki","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2009.09.041_bib38","series-title":"GeodonR (ziprasidone HCl), GeodonR (ziprasidone mesylate) for injection for IM use only prescribing information","author":"Pfizer","year":"2007"},{"key":"10.1016\/j.schres.2009.09.041_bib39","first-page":"327","article-title":"Antipsychotics and prolongation of the QTc interval: a clinical study","volume":"42","author":"Polselli","year":"2007","journal-title":"Riv. Psichiatr."},{"key":"10.1016\/j.schres.2009.09.041_bib40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death","volume":"360","author":"Ray","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.schres.2009.09.041_bib41","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(00)02035-3","article-title":"QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients","volume":"355","author":"Reilly","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2009.09.041_bib42","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/01.jcp.0000162799.64378.fc","article-title":"QTc variability in schizophrenia patients treated with antipsychotics and healthy controls","volume":"25","author":"Rettenbacher","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2009.09.041_bib43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00004850-198904000-00001","article-title":"Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics","volume":"4","author":"Rey","year":"1989","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2009.09.041_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1744-859X-4-1","article-title":"QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy","volume":"4","author":"Sala","year":"2005","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2009.09.041_bib45","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archinte.166.8.909","article-title":"Prognostic impact of prolonged ventricular repolarization in hypertension","volume":"166","author":"Schillaci","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.schres.2009.09.041_bib46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00004850-198904000-00002","article-title":"Guidelines for the dosage of neuroleptics. II: Changing from daily oral to long acting injectable neuroleptics","volume":"4","author":"Schulz","year":"1989","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2009.09.041_bib47","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1253\/circj.69.409","article-title":"Sex difference in the relationship between insulin resistance and corrected QT interval in non-diabetic subjects","volume":"69","author":"Shin","year":"2005","journal-title":"Circ. J."},{"key":"10.1016\/j.schres.2009.09.041_bib48","first-page":"140","article-title":"Effect of smoking on QT interval, QT dispersion and rate pressure product","volume":"56","author":"Singh","year":"2004","journal-title":"Indian Heart J."},{"key":"10.1016\/j.schres.2009.09.041_bib49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1744-859X-6-13","article-title":"QTc and psychopharmacs: are there any differences between monotherapy and polytherapy","volume":"6","author":"Sumi\u0107","year":"2007","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2009.09.041_bib50","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4088\/JCP.v66n0203","article-title":"Obesity and associated complications in patients with severe mental illnesses: a cross-sectional survey","volume":"66","author":"Susce","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2009.09.041_bib51","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1034\/j.1600-0447.2003.02078.x","article-title":"Antipsychotics and QT prolongation","volume":"107","author":"Taylor","year":"2003","journal-title":"Acta Psychiatr. Scand."},{"issue":"suppl 9","key":"10.1016\/j.schres.2009.09.041_bib52","first-page":"18","article-title":"Mechanisms and risks of electrocardiographic QT interval prolongation when using antipsychotic drugs","volume":"63","author":"Vieweg","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2009.09.041_bib53","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1192\/bjp.173.4.325","article-title":"Mortality in schizophrenia. Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study","volume":"173","author":"Waddington","year":"1998","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2009.09.041_bib54","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1600-0447.1996.tb10653.x","article-title":"Electrocardiographic changes in patients receiving neuroleptic medication","volume":"93","author":"Warner","year":"1996","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2009.09.041_bib55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/clc.4950250203","article-title":"Gender differences in arrhythmias","volume":"25","author":"Wolbrette","year":"2002","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.schres.2009.09.041_bib56","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"Woods","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2009.09.041_bib58","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1023\/A:1024122706337","article-title":"Antipsychotic drugs and QT interval prolongation","volume":"74","author":"Zareba","year":"2003","journal-title":"Psychiatr. Q."},{"key":"10.1016\/j.schres.2009.09.041_bib57","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1055\/s-2006-924083","article-title":"Selective contribution of diabetes and other cardiovascular risk factors to cardiac autonomic dysfunction in the general population","volume":"114","author":"Ziegler","year":"2006","journal-title":"Exp. Clin. Endocrinol. Diabetes"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099640900485X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099640900485X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T15:20:34Z","timestamp":1544887234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092099640900485X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S092099640900485X"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2009.09.041","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}